Craig Hallum cut shares of CAS Medical Systems (NASDAQ:CASM) from a buy rating to a hold rating in a research note released on Tuesday, The Fly reports.
Shares of CASM stock opened at $2.42 on Tuesday. The firm has a market cap of $45.80 million, a price-to-earnings ratio of -8.96 and a beta of 0.45. CAS Medical Systems has a 12 month low of $0.99 and a 12 month high of $2.70.
A number of hedge funds have recently made changes to their positions in the business. Vanguard Group Inc increased its stake in CAS Medical Systems by 2.8% during the 3rd quarter. Vanguard Group Inc now owns 547,560 shares of the medical technology company’s stock valued at $1,249,000 after purchasing an additional 15,155 shares in the last quarter. Douglas Lane & Associates LLC bought a new stake in CAS Medical Systems during the 4th quarter valued at $54,000. BlackRock Inc. increased its stake in CAS Medical Systems by 569.2% during the 2nd quarter. BlackRock Inc. now owns 84,091 shares of the medical technology company’s stock valued at $164,000 after purchasing an additional 71,525 shares in the last quarter. Renaissance Technologies LLC increased its stake in CAS Medical Systems by 47.2% during the 2nd quarter. Renaissance Technologies LLC now owns 386,539 shares of the medical technology company’s stock valued at $754,000 after purchasing an additional 123,939 shares in the last quarter. Finally, Ingalls & Snyder LLC bought a new stake in CAS Medical Systems during the 3rd quarter valued at $1,142,000. Institutional investors and hedge funds own 27.92% of the company’s stock.
CAS Medical Systems, Inc, a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations.
Receive News & Ratings for CAS Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CAS Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.